Skip to content
Home/Companies/Biotech/Bota Bio
Bota Bio

Bota Bio

Biotech·China·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns Bota Bio?

Bota Bio is currently owned by BASF Venture Capital through BASF Venture Capital Evergreen Fund (2001 vintage), since 2021.

Hand-verified · updated 2026-08-10

BASF Venture Capital
Investor
BASF Venture Capital
BASF Venture Capital Evergreen Fund · 2001 · Evergreen

Key facts

HQChina
SectorBiotech
StatusActive
Websitebota.bio

More from BASF Venture Capital Evergreen Fund

Other portfolio companies in the same fund.

ACT-ion Battery Technologies
ACT-ion Battery Technologies
Active
ClimateTechUnited States· 2025
Grao Direto
Active
AgTechBrazil· 2024
DePoly
DePoly
Active
ClimateTechSwitzerland· 2023
pH7 Technologies
pH7 Technologies
Active
ClimateTechCanada· 2023
Phomera Metamaterials
Active
Deep TechChina· 2023
WayBeyond
WayBeyond
Active
AgTechNew Zealand· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track Bota Bio

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Bota Bio.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue